<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><label>Table 1.</label><caption><title>Overview of peptides used in MARTINI simulations and observed pore structures.</title></caption><table frame="hsides" rules="groups"><thead><tr><th>Peptide</th><th>Variant</th><th>Sequence and secondary structure</th><th>Pore&#8224;</th></tr></thead><tbody><tr><td>LL-37</td><td>WT</td><td><monospace><named-content content-type="sequence"><bold>LLG</bold>DFFRKSK EKI<bold>G</bold>KEFKRI</named-content> <named-content content-type="sequence">VQRIKDFLRN LV<bold>PRTES</bold></named-content></monospace></td><td>HG</td></tr><tr><td/><td>WT*</td><td><monospace><named-content content-type="sequence"><bold>LLG</bold>DFFRKSK EKIGKEFKRI</named-content> <named-content content-type="sequence">VQRIKDFLRN LV<bold>PRTES</bold></named-content></monospace></td><td>&#8211;</td></tr><tr><td/><td>G14L</td><td><monospace><named-content content-type="sequence"><bold>LLG</bold>DFFRKSK EKI<underline>L</underline>KEFKRI</named-content> <named-content content-type="sequence">VQRIKDFLRN LV<bold>PRTES</bold></named-content></monospace></td><td>&#8211;</td></tr><tr><td/><td>I13G/G14I</td><td><monospace><named-content content-type="sequence">LLGDFFRKSK EK<bold><underline>G</underline></bold><underline>I</underline>KEFKRI</named-content><named-content content-type="sequence">VQRIKDFLRN LV<bold>PRTES</bold></named-content></monospace></td><td>U</td></tr><tr><td>Buforin II</td><td>WT</td><td><monospace><named-content content-type="sequence">TRSSRAGLQ<bold>F PV</bold>GRVHRLLR K</named-content></monospace></td><td>&#8211;</td></tr><tr><td/><td>WT*</td><td><monospace><named-content content-type="sequence">TRSSRAGLQF PVGRVHRLLR K</named-content></monospace></td><td>BP</td></tr><tr><td/><td>P11L</td><td><monospace><named-content content-type="sequence">TRSSRAGLQF <underline>L</underline>VGRVHRLLR K</named-content></monospace></td><td>BP</td></tr><tr><td/><td>P11A</td><td><monospace><named-content content-type="sequence">TRSSRAGLQF <underline>A</underline>VGRVHRLLR K</named-content></monospace></td><td>BP</td></tr><tr><td/><td>P11G</td><td><monospace><named-content content-type="sequence">TRSSRAGLQ<bold>F <underline>G</underline>V</bold>GRVHRLLR K</named-content></monospace></td><td>&#8211;</td></tr><tr><td/><td>P11G*</td><td><monospace><named-content content-type="sequence">TRSSRAGLQF <underline>G</underline>VGRVHRLLR K</named-content></monospace></td><td>BP</td></tr><tr><td/><td>P11G^</td><td><monospace><named-content content-type="sequence">TRSSRAGLQF <bold><underline>G</underline></bold>VGRVHRLLR K</named-content></monospace></td><td>BP/TP</td></tr><tr><td>Magainin 2</td><td>WT</td><td><monospace><named-content content-type="sequence">GIGKFLHSAK K<bold>FGK</bold>AFVGEI</named-content> <named-content content-type="sequence">MNS</named-content></monospace></td><td>TP</td></tr><tr><td/><td>WT*</td><td><monospace><named-content content-type="sequence">GIGKFLHSAK KFGKAFVGEI</named-content> <named-content content-type="sequence">MNS</named-content></monospace></td><td>SP</td></tr><tr><td/><td>G13P</td><td><monospace><named-content content-type="sequence">GIGKFLHSAK K<bold>F<underline>P</underline>K</bold>AFVGEI</named-content> <named-content content-type="sequence">MNS</named-content></monospace></td><td>TP</td></tr><tr><td/><td>G13P*</td><td><monospace><named-content content-type="sequence">GIGKFLHSAK KF<underline>P</underline>KAFVGEI</named-content> <named-content content-type="sequence">MNS</named-content></monospace></td><td>SP</td></tr><tr><td>&#948;-lysin</td><td>WT</td><td><monospace><named-content content-type="sequence">MAQDIIST<bold>IG D</bold>LVKWIIDTV</named-content> <named-content content-type="sequence">NKFTKK</named-content></monospace></td><td>SP</td></tr><tr><td/><td>WT*</td><td><monospace><named-content content-type="sequence">MAQDIISTIG DLVKWIIDTV</named-content> <named-content content-type="sequence">NKFTKK</named-content></monospace></td><td>TP</td></tr><tr><td>CandK</td><td>WT</td><td><monospace><named-content content-type="sequence">SIIGIIMGIL GNI<bold>P</bold>QVIQII</named-content> <named-content content-type="sequence">MSIVKAFKGN</named-content> <named-content content-type="sequence">K</named-content></monospace></td><td>U</td></tr><tr><td/><td>WT*</td><td><monospace><named-content content-type="sequence">SIIGIIMGIL GNIPQVIQII</named-content> <named-content content-type="sequence">MSIVKAFKGN K</named-content> </monospace></td><td>TP</td></tr><tr><td>CandKR</td><td>WT</td><td><monospace><named-content content-type="sequence">SIIGIIMGIL GNI<bold>P</bold>QVIQII</named-content> <named-content content-type="sequence">MSIVKAFKGN KR</named-content></monospace></td><td>U</td></tr><tr><td/><td>P14Q/Q15P</td><td><monospace><named-content content-type="sequence">SIIGIIMGIL GNI<underline>Q<bold><underline>P</underline></bold></underline>VIQII</named-content> <named-content content-type="sequence">MSIVKAFKGN KR</named-content></monospace></td><td>HG</td></tr></tbody></table><table-wrap-foot><fn><p>Sequence color coding: &#945;-helix&#160;=&#160;roman, unstructured&#160;=&#160;bold. Amino acid substitutions in the peptide sequences are underlined.</p><p>&#8727; a sequence where glycine/proline (usually a kink-forming residues) was forced into an &#945;-helix.</p></fn><fn><p>^ a sequence where only single residue was defined to be unstructured.</p><p>&#8224;Toroidal pore (TP); Disordered toroidal pore (DTP); Barrel-stave pore (BP); Hourglass pore (HG); U-shaped pore (U); Synergistic Pore (SP); No pore formation (&#8211;).</p></fn></table-wrap-foot></table-wrap>